LifeTech Scientific Corp
HKEX:1302

Watchlist Manager
LifeTech Scientific Corp Logo
LifeTech Scientific Corp
HKEX:1302
Watchlist
Price: 1.46 HKD 0.69% Market Closed
Market Cap: 6.4B HKD
Have any thoughts about
LifeTech Scientific Corp?
Write Note

LifeTech Scientific Corp
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LifeTech Scientific Corp
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
LifeTech Scientific Corp
HKEX:1302
Cash from Investing Activities
-ÂĄ409.4m
CAGR 3-Years
16%
CAGR 5-Years
1%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash from Investing Activities
ÂĄ581.9m
CAGR 3-Years
840%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash from Investing Activities
ÂĄ241.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash from Investing Activities
-ÂĄ3.1B
CAGR 3-Years
23%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash from Investing Activities
-ÂĄ2.3B
CAGR 3-Years
-31%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash from Investing Activities
-ÂĄ1.6B
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LifeTech Scientific Corp
Glance View

Market Cap
6.8B HKD
Industry
Health Care

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

Intrinsic Value
2.06 HKD
Undervaluation 29%
Intrinsic Value
Price

See Also

What is LifeTech Scientific Corp's Cash from Investing Activities?
Cash from Investing Activities
-409.4m CNY

Based on the financial report for Jun 30, 2024, LifeTech Scientific Corp's Cash from Investing Activities amounts to -409.4m CNY.

What is LifeTech Scientific Corp's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
1%

Over the last year, the Cash from Investing Activities growth was 8%. The average annual Cash from Investing Activities growth rates for LifeTech Scientific Corp have been 16% over the past three years , 1% over the past five years .

Back to Top